Simplex Trading
SGMT icon

Simplex Trading’s Sagimet Biosciences SGMT Stock Holding History

Simplex Trading’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Buy
45,700
+14,800
+48% +$101K ﹤0.01% 4030
2026
Q1 		$161K Buy
30,900
+800
+3% +$4.46K ﹤0.01% 4557
2025
Q4 		$178K Buy
30,100
+13,000
+76% +$93.4K ﹤0.01% 4346
2025
Q3 		$117K Buy
17,100
+1,300
+8% +$10.5K ﹤0.01% 5564
2025
Q2 		$120K Buy
15,800
+7,500
+90% +$31.7K ﹤0.01% 5055
2025
Q1 		$27K Sell
8,300
-22,000
-73% -$92.3K ﹤0.01% 6340
2024
Q4 		$136K Buy
30,300
+4,400
+17% +$22.3K ﹤0.01% 4896
2024
Q3 		$71K Sell
25,900
-5,100
-16% -$15.7K ﹤0.01% 5555
2024
Q2 		$106K Buy
+31,000
New +$142K ﹤0.01% 5324

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Simplex Trading's SGMT Position: Q2 2026 in Review

Simplex Trading sold out of Sagimet Biosciences (SGMT) in Q2 2026, closing a stake of 13,636 shares — an estimated $92.7K sold.

Simplex Trading first reported a position in SGMT in Q2 2024 and held it in 6 quarters. The position peaked at $84.2K in Q4 2025. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Simplex Trading reported no remaining Sagimet Biosciences position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 13,636 Sagimet Biosciences shares in Q2 2026, an estimated $92.7K.
  • Simplex Trading first reported a position in Sagimet Biosciences in Q2 2024 and held it in 6 quarters.
  • Simplex Trading's Sagimet Biosciences position peaked at $84.2K in Q4 2025.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.